Learn from an Advarra IRB Expert about the FDA’s Guidance on Clinical Trials during Coronavirus

James Riddle, Advarra’s Vice President of Institutional Services, provides his insights on how his IRB is responding to COVID-19-related requests, the recent rise of virtual and at-home visits, and how the FDA’s most recent guidance offers flexibility to sponsors and sites alike.

Advarra is the largest central IRB for pharmaceutical trials.

Learn More About CRIO

BOOK A 20-MINUTE DEMO TO LEARN ABOUT OUR PRODUCT